Sign In
Buy SNN
$29.36
-0.120 (-0.407%)
At Close: Jun 02, 2026
Smith & Nephew tops Footsie after bullish sales update
03:53am, Wednesday, 01'st May 2024
Smith & Nephew jumped to the top of the FTSE 100 as the UK MedTech delivered a confident first-quarter update and reiterated revenues would grow strongly over the remainder of the year. Sales were up
U.K. Top 40 Quality Dividend Stocks: Q2 2024
01:30pm, Friday, 12'th Apr 2024
The list ranks stocks based on their market cap and dividend yield alone. What I am looking for is quality dividend stocks with long track records of progressive dividend growth, and while dividend yi
Smith+Nephew (SNN) Expands in Australia With New Alliance
10:16am, Thursday, 11'th Apr 2024
The latest partnership allows Smith+Nephew (SNN) to complement its existing implant range with the cutting-edge navigation technology of NAVBIT.
Smith+Nephew signs exclusive distribution agreement to provide unique NAVBIT SPRINT™ solution in Australia
06:00pm, Monday, 08'th Apr 2024
Compact, single-use, and simple-to-use technology offers surgeons a fast, reliable navigation solution for hip arthroplasty Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, anno
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the review of medical technologies guidance from the UK National Institute for Health and Care Excellence (NICE
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, is pleased to announce the launch of its RENASYS EDGE Negative Pressure Wound Therapy (NPWT) System in the US as a patient-centr
Smith+Nephew teams up with UFC to be first-ever Preferred Sports Medicine Technology Partner
08:00am, Monday, 25'th Mar 2024
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has been named the Preferred Sports Medicine Technology Partner of UFC – the world's premier mixed martial
7 Robotic Surgery Stocks to Buy for the Future of Healthcare
04:30pm, Wednesday, 13'th Mar 2024
There are some robotic surgery stocks for investors to buy in March this year. The growth of robotic-assisted surgery has been driven by its potential benefits, such as smaller incisions, reduced pain
Smith & Nephew: Scepticism has been overplayed, says leading investment bank
10:25am, Monday, 11'th Mar 2024
JP Morgan has spotlighted Smith & Nephew PLC (LSE:SN) for its revenue acceleration and margin expansion potential, setting a price target of 1,300p - a 21% premium to the current stock price. Despite
Smith & Nephew plc (SNN) Q4 2023 Earnings Call Transcript
01:13am, Wednesday, 28'th Feb 2024
Smith & Nephew plc (SNN) Q4 2023 Earnings Call Transcript
Smith & Nephew profits meet targets, 'robust' growth expected in 2024
03:08am, Tuesday, 27'th Feb 2024
Smith & Nephew PLC (LSE:SN) kept its dividend unchanged and guided to solid growth this year as it reported 2023 results in line with improved guidance from last summer. The hip and knee replacement s
3 Millionaire-Maker Robotics Stocks to Buy in February 2024
04:40pm, Wednesday, 21'st Feb 2024
There are some key robotics stocks for investors to buy in February. This is amid the broader indices such as the Nasdaq making a brief pullback.
Are Investors Undervaluing Smith & Nephew SNATS (SNN) Right Now?
10:46am, Wednesday, 21'st Feb 2024
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces full commercial availability of its AETOS Shoulder System in the US, along with 510(k) clearance for its use wit
Smith+Nephew (LSE: SN, NYSE:SNN), the global medical technology company, announces it will provide a glimpse into the future at AAOS 2024. With a first opportunity to see a forthcoming new feature* fo
